Neumora Therapeutics (NMRA) Shares Decline Amid Market Fluctuations
Neumora Therapeutics (NMRA) closed the trading session on Wednesday, 21 March 2026, down 1.06 % at 01:54 PM Central Europe. At the close, the stock traded at approximately USD 0.47 on major exchanges.
Market Overview
- Shares outstanding: 187.9 million
- Market capitalization: USD 88.3 million
- Volume (last 24 h): USD 453 000 worth of shares traded
- Year‑to‑date performance: Decrease of 32.8 % since the end of the previous month
- 200‑day simple moving average: USD 1.85
- 52‑week high: USD 3.65 (recorded on 18 February 2026)
- 52‑week low: USD 0.32 (recorded on 14 October 2026)
Recent Performance of Peer Companies
| Ticker | 24‑h Change | Current Price (USD) | Market Capitalization (USD) |
|---|---|---|---|
| SRFM – Surf Air Mobility | +3.55 % | 0.88 | 104.6 million |
| RTB – Rtb Digital | +3.06 % | 7.75 | 105.3 million |
| BDTX – Black Diamond Therapeutics I | +14.36 % | 2.07 | 104 million |
| UFI – Unifi | –2.33 % | 5.46 | 103.9 million |
| PNBK – Patriot National | +11.25 % | 0.88 | 104.6 million |
Company Background
Neumora Therapeutics, Inc. is a clinical‑stage biopharmaceutical company headquartered in Watertown, United States. The company focuses on the discovery, development, and commercialization of targeted therapies for brain diseases. Its mission is to improve patient outcomes and quality of life by advancing treatment options for neurological disorders.
